Comparative assessment of leukotriene levels in different forms of rhinitis


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. Leukotrienes (LT) as the products of the lipoxygenase mechanism of the metabolism of arachidonic acid play a significant role in the development of the inflammatory response in allergic rhinitis (АЙ) and АЙ in combination with chronic rhinosinusitis of bacterial etiology (CRSBE). Objective. Comparative assessment of the role of leukotrienes LT C4, D4, E4 and LT B4 in АЙ and АЙ with CRSBE. Methods. 83 patients with the studied forms of rhinitis aged 18 to 55 years were examined (40 patients with АЙ, 43 patients with АЙ with CRSBE). The control group included 27 apparently healthy individuals. The plasma LT levels were determined by enzyme immunoassay. In order to determine the threshold values of LT C4, D4, E4 and LT B4 levels in АЙ and АЙ with CRSBE, an ROC analysis was performed. Results. The total LT C4, D4, E4 levels are of decisive importance in the development and maintenance of the allergic mechanism of inflammation, while LTB4 predominates in the formation of a purulent-inflammatory process in these forms of rhinitis. In АЙ and АЙ with CRSBE, a high level of total LT C4, D4, E4 (3.60±0.18 ng/ml and 3.25±0.16 ng/ml, respectively) was observed in comparison with the indicators of the control group (0.64±0.12 ng/ml; p<0.05). The LTB4 level was significantly increased only in patients with АЙ with CRSBE, amounting to 14.43±0.57 ng/ml (p<0.05), while in АЙ this indicator did not differ from the values in the control group (1.89±0.19 and 1.52±0.21 ng ml, respectively). The ROC analysis of the LT level showed that the threshold value of the LT C4, D4, E4 was 1.53 ng/ ml between AR patients and healthy ones (test sensitivity 95.0%, specificity 96.3%); 1.47 ng/ml between AR patients with CRSBE and healthy ones (test sensitivity 95.3%, specificity 96.3%). For LTB4, the threshold value was 6.24 ng/ml between AR patients and AR patients with CRSBE (test sensitivity 95.3%, specificity 100.0%); 5.74 ng/ml between AR patients with CRSBE and healthy ones (test sensitivity 97.7%, specificity 100.0%). Conclusion. LT make a significant contribution to the development of an inflammatory response in the nasal mucosa in AR and AR with CRSBE. A significant role of total LT C4, D4, E4 was revealed both in AR and AR with CRSBE. These LT are responsible for the allergic component of the inflammatory response, which is consistent with the literature data. The level of LTB4, which directly supports the infectious component of inflammation in the mucous membrane of the upper respiratory tract, is elevated only in AR with CRSBE.

Full Text

Restricted Access

About the authors

E. A Orlova

Penza Institute for Advanced Medical Education - Branch of the Russian Medical Academy of Continuous Professional Education

Email: lisaol@yandex.ru
Professor at the Department of Allergology and Immunology 8A, Stasova str., Penza 440060, Russian Federation

E. M Kostina

Penza Institute for Advanced Medical Education - Branch of the Russian Medical Academy of Continuous Professional Education

Penza, Russia

O. A Kulikova

Penza Institute for Advanced Medical Education - Branch of the Russian Medical Academy of Continuous Professional Education

Penza, Russia

O. A Levashova

Penza State University

Penza, Russia

S. A Sokolov

OOO “Ergomed Clinical Research"

Moscow, Russia

References

  1. Астафьева Н.Г., Кобзев Д.Ю., Гамова И.В. и др. Многоликий ринит: современный взгляд на диагностику и алгоритм лечения. Лечащий Врач. 2018;4:7-18.
  2. Булкина О.З.. Оптимизация комплексного лечения круглогодичного аллергичкого ринита, осложненного очагами хронической инфекции рото- и носоглотки. Дисс. канд. мед. наук. М., 2009
  3. Лопатин А.С. Ринит. Руководство для врачей. М.: Литтерра, 2010
  4. Li K.L., Lee A.Y., Abuzeid W.M. Aspirin Exacerbated Respiratory Disease: Epidemiology, Pathophysiology, and Management. Med Sci (Basel). 2019;7(3):25-42. Doi: 10.3390/ medsci7030045.
  5. Divekar R, Hagan J., Rank M, et al. Diagnostic Utility of Urinary LTE4 in Asthma, Allergic Rhinitis, Chronic Rhinosinusitis, Nasal Polyps, and Aspirin Sensitivity J Allergy Clin immunol Pract. 2016;4(4):665-70. Doi: 10.1016/j. jaip.2016.03.004.
  6. Жарких М, Яблонский С., Мокроносова М. Значение лейкотриенов и антилейкотриеновых препаратов при аллергическом рините. Педиатрическая фармакология. 2009;6(5):20-9.
  7. Peters-Golden M., Gleason M.M., Togias A. Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis. Clin Exp Allergy. 2006;36(6):689-703. doi: 10.1111/j.1365-2222.2006.02498.x.
  8. Peters-Golden M. intracellular compartmentalization of leukotriene synthesis: unexpected nuclear secrets. FEBS Lett. 2001;487:323-26.
  9. Bousquet J. Pathophysiology of allergic rhinitis. int Arch Allergy immunol. 1996;110:207-18.
  10. Княжеская Н.П. Аспириновая бронхиальная астма и антагонисты лейкотриенов. Российский медицинский журнал. 2000;8(12):505-9. Интернет-публикация: http://www.rmj.ru/ articles_1639.htm.48
  11. Пыцкий В.А., Адрианова Н.В., Артомасова А.В. Аллергические заболевания. М.: Медицина, 1999.
  12. Lee T.H., Woszczek G., Farooque S.P Leukotriene E4: perspective on the forgotten mediator. J Allergy Clin immunol. 2009;124(3):417-21. doi: 10.1016/j.jaci.2009.04.020.
  13. Wenzel S.E. The role of leukotrienes in asthma. Prostaglandins, leukotrienes, and essential fatty acids. 2003;69(2-3):145-55. Doi: 10.1016/ s0952-3278(03)00075-9.
  14. McMillan R.M. Leukotrienes in respiratory disease. Paediatr Respir Rev. 2001;2(3):238-44. doi: 10.1053/prrv.2001.0146.
  15. Wan M., Tang X., Stsiapanava A., et al. Biosynthesis of leukotriene B(4). Semin immunol. 2017;33:3-15. doi: 10.1016/j.smim.2017.07.012.
  16. Malaviya R., Abraham S.N. Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis. J Leukoc Biol. 2000;67(6):841-46. Doi: 10.1002/ jlb.67.6.841.
  17. Beck-Speier i., Dayal N., Karg E., et al. Oxymetazoline inhibits proinflammatory reactions: effect on arachidonic acid-derived metabolites. J Pharmacol Exp Ther. 2006;316(2):843-51. Doi: 10.1124/ jpet.105.093278.
  18. Fokkens W.J., Lund V.J., Mullol J., et al. European Position Paper on Rhinosinusitis and Nasal Polyps. Rhinology. 2012. 299 p.
  19. Brozek J.L., Bousquet J., Agache i., et al. Allergic Rhinitis and its impact on Asthma (ARiA) Guidelines - 2016 Revision. J Allergy Clin immunol. 2017;140:950-58.
  20. Cingi C., Muluk N.B., ipci K., et al. Antileukotrienes in upper airway inflammatory diseases. Curr Allergy Asthma Rep. 2015;15(11):64. Doi: 10.1007/ s11882-015-0564-7.
  21. Liu M., Yokomizo T. The role of leukotrienes in allergic diseases. Allergol int. 2015;64(1):17-26. doi: 10.1016/j.alit.2014.09.001.
  22. Ohnishi H., Miyahara N., Gelfand E.W. The role of leukotriene B(4) in allergic diseases. Allergolint. 2008;57(4):291-98. Doi: 10.2332/ allergolint.08-RAi-0019.
  23. Bachert C., Zhang N., Patou J., et al. Role of staphylococcal superantigens in upper airway disease. Curr Opin Allergy Clin immunol. 2008; 8(1):34-8. Doi: 10.1097/ ACi.0b013e3282f4178f.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2020 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies